Indication
Retinal Neoplasm
2 clinical trials
7 products
1 drug
Clinical trial
Conservative Treatments of RetinoblastomaStatus: Active (not recruiting), Estimated PCD: 2023-01-01
Product
VP16Drug
MelphalanProduct
CarboplatinProduct
MelphalanClinical trial
Protocol for the Study and Treatment of Patients With Intraocular RetinoblastomaStatus: Active (not recruiting), Estimated PCD: 2013-11-01
Product
VincristineProduct
Vincristine + Topotecan